Published in Vaccine Weekly, January 31st, 2001
"DC can modulate the nature of immune responses in a stimulatory or tolerogenic fashion," wrote Y.M. Huang and colleagues, Huddinge University Hospital, Karolinska Institute. "Great attention has been given to the induction of immunity to tumor and infection. In this study, bone marrow-derived DC from healthy Lewis rats were pulsed in vitro with encephalitogenic myelin basic protein peptide 68-86 (MBP 68-86), and injected subcutaneously (1x106/rat) into normal Lewis rats."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.